Market Performance
Patel Chem Specialities Ltd made a robust debut on the BSE SME platform on August 1, with its shares listing at ₹110 per share.
- IPO Price: ₹84
- Listing Price: ₹110
- Premium: ~31%
The company’s listing came on the back of strong investor demand, reflecting positive sentiment toward its business in pharmaceutical excipients and specialty chemicals.
Main News
Patel Chem Specialities saw heightened interest during its three-day IPO bidding window, which ran from July 25 to July 29.
- Subscription Rate: 167 times the offer size
- IPO Issue Size: ₹59 crore
- Fresh Issue: 70 lakh equity shares
- Price Band: ₹82–₹84 per share
The significant oversubscription highlighted the overwhelming response from both retail and institutional investors.
Company Details
The company is engaged in the production of pharmaceutical excipients and specialty chemicals. It entered the public market with a valuation of over ₹200 crore.
- Minimum Retail Investment: ₹1.31 lakh (1,600 shares)
- Anchor Investment (Pre-IPO): ₹16.69 crore
- Anchor Shares Allotted: 19.87 lakh shares
- Anchor Investors: Bengal Finance, Meru Investment Fund, Zeal Global Opportunities Fund, Necta Bloom, Belgrave Investment Fund
Funds raised from the IPO are earmarked for capital expenditure and general corporate purposes. The issue was managed by Cumulative Capital and Unistone Capital.
Summary of the Article
Patel Chem Specialities share price listed at ₹110, marking a 31% gain over the IPO price of ₹84. The stock's strong debut reflects high investor confidence and interest in the company's niche segment. The IPO garnered 167x subscription, with pre-IPO anchor funding further cementing its robust market entry.
With the company now trading on the BSE SME, market observers will keep a close eye on its post-listing performance.
Leave A Comment?